These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6769814)

  • 1. Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier.
    Galelli A; Le Garrec Y; Chedid L; Lefrancier P; Derrien M; Level M
    Infect Immun; 1980 Apr; 28(1):1-5. PubMed ID: 6769814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.
    Tanaka A; Nagao S; Imai K; Mori R
    Microbiol Immunol; 1980; 24(6):547-57. PubMed ID: 7412595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue.
    Audibert F; Parant M; Damais C; Lefrancier P; Derrien M; Choay J; Chedid L
    Biochem Biophys Res Commun; 1980 Sep; 96(2):915-23. PubMed ID: 7426019
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
    Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
    Carelli C; Audibert F; Chedid L
    Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
    Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
    J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition.
    Kohashi O; Tanaka A; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S; Ozawa A
    Infect Immun; 1980 Jul; 29(1):70-5. PubMed ID: 7399708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4.
    Vidal VF; Castéran N; Riendeau CJ; Kornfeld H; Darcissac EC; Capron A; Bahr GM
    Eur J Immunol; 2001 Jul; 31(7):1962-71. PubMed ID: 11449348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S; Fidler IJ
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
    J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
    Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
    J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
    Azuma I; Kamisango KI; Saiki I; Tanio Y; Kobayashi S; Yamamura Y
    Infect Immun; 1980 Sep; 29(3):1193-6. PubMed ID: 7429634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central pyrogenic activity of muramyl dipeptide.
    Riveau G; Masek K; Parant M; Chedid L
    J Exp Med; 1980 Oct; 152(4):869-77. PubMed ID: 7420023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shortened synthesis of adjuvant dipeptide (MDP).
    Schwartzman SM; Ribi E
    Prep Biochem; 1980; 10(3):255-67. PubMed ID: 7413603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
    Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
    Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
    Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
    Fraser-Smith EB; Matthews TR
    Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.